Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukemia with normal karyotype. Radiol Oncol [Internet]. 2016 Nov. 21 [cited 2026 Nov. 4];50(4). Available from: https://www.radioloncol.com/index.php/ro/article/view/2580